W
William Small
Researcher at Loyola University Chicago
Publications - 423
Citations - 15241
William Small is an academic researcher from Loyola University Chicago. The author has contributed to research in topics: Radiation therapy & Brachytherapy. The author has an hindex of 56, co-authored 396 publications receiving 12744 citations. Previous affiliations of William Small include University of Hong Kong & University of Chicago.
Papers
More filters
Journal ArticleDOI
A Multi-Institutional Phase II Trial of Preoperative Full-Dose Gemcitabine and Concurrent Radiation for Patients With Potentially Resectable Pancreatic Carcinoma
Mark S. Talamonti,William Small,Mary F. Mulcahy,Jeffrey D. Wayne,Vikram Attaluri,Lisa M. Colletti,Mark M. Zalupski,John P. Hoffman,Gary M. Freedman,Timothy J. Kinsella,Philip A. Philip,Cornelius J. McGinn +11 more
TL;DR: Preoperative gemcitabine/radiotherapy is well tolerated and safe when delivered in a multi-institutional setting, with acceptable morbidity, and the high rate of negative margins and uninvolved nodes suggests a significant tumor response.
Journal ArticleDOI
ACR Appropriateness Criteria® Right Lower Quadrant Pain--Suspected Appendicitis.
Martin P. Smith,Douglas S. Katz,Tasneem Lalani,Laura R. Carucci,Brooks D. Cash,David H. Kim,Robert J. Piorkowski,William Small,Stephanie Spottswood,Mark Tulchinsky,Vahid Yaghmai,Judy Yee,Max P. Rosen +12 more
TL;DR: This narrative's focus is on imaging procedures in the diagnosis of AA, with consideration of other diseases causing RLQ pain, which is the most common cause of acute right lower quadrant (RLQ) pain.
Journal ArticleDOI
Patient-Reported Toxicity During Pelvic Intensity-Modulated Radiation Therapy: NRG Oncology-RTOG 1203.
Ann H. Klopp,Anamaria R. Yeung,Snehal Deshmukh,Karen M. Gil,Lari Wenzel,Shannon N. Westin,Kent A Gifford,David K. Gaffney,William Small,Spencer Thompson,Desiree E. Doncals,Guilherme Cantuaria,Brian Yaremko,Amy T.Y. Chang,Vijayananda Kundapur,D.S. Mohan,Michael L. Haas,Yong Bae Kim,C.L. Ferguson,Stephanie L. Pugh,Lisa A. Kachnic,Deborah Watkins Bruner +21 more
TL;DR: Pelvic IMRT was associated with significantly less GI and urinary toxicity than standard RT from the patient's perspective, and quality of life measured with the Trial Outcome Index.
Journal ArticleDOI
Phase III Trial: Adjuvant Pelvic Radiation Therapy Versus Vaginal Brachytherapy Plus Paclitaxel/Carboplatin in High-Intermediate and High-Risk Early-Stage Endometrial Cancer
Marcus E. Randall,Virginia L. Filiaci,D. Scott McMeekin,Vivian E. von Gruenigen,Helen J. Huang,Catheryn M. Yashar,Robert S. Mannel,Jae Weon Kim,Ritu Salani,Paul DiSilvestro,James J. Burke,Thomas J. Rutherford,Nick M. Spirtos,Keith Terada,Penny R. Anderson,Wendy R. Brewster,William Small,Carol Aghajanian,David Miller +18 more
TL;DR: Pelvic RT alone remains an effective, well-tolerated, and appropriate adjuvant treatment in high-risk early-stage endometrial carcinomas of all histologies.
Journal ArticleDOI
Automatic Patient Centering for MDCT: Effect on Radiation Dose
TL;DR: Surfaces doses can be reduced if radiologic technologists can better center patients within the CT gantry and result in as much as 30% reduction in surface dose.